Evidence map›Paper›PMID 38140159›Full record

ArticleVaccines2023

Inapparent Tick-Borne Orthoflavivirus Infection in

Victoria Illarionova, Anastasia Rogova, Ksenia Tuchynskaya, Viktor Volok, Yulia Rogova, Victoria Baryshnikova, Yuriy Turchenko, Alexander Litov, Anna Kalyanova, Alexandra Siniugina and 2 more

Open access · goldAbstract read
In one paragraph

Article in Vaccines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Victoria IllarionovaFSASI "Chumakov FSC R&D IBP RAS" (Institute of Poliomyelitis), Laboratory of Biology of Arbovirus, Moscow 108819, Russia.
Anastasia RogovaFSASI "Chumakov FSC R&D IBP RAS" (Institute of Poliomyelitis), Laboratory of Biology of Arbovirus, Moscow 108819, Russia.
Ksenia TuchynskayaFSASI "Chumakov FSC R&D IBP RAS" (Institute of Poliomyelitis), Laboratory of Biology of Arbovirus, Moscow 108819, Russia.ORCID 0000-0001-5668-3603
Viktor VolokFSASI "Chumakov FSC R&D IBP RAS" (Institute of Poliomyelitis), Laboratory of Biology of Arbovirus, Moscow 108819, Russia.
Yulia RogovaFSASI "Chumakov FSC R&D IBP RAS" (Institute of Poliomyelitis), Laboratory of Biology of Arbovirus, Moscow 108819, Russia.
Victoria BaryshnikovaFSASI "Chumakov FSC R&D IBP RAS" (Institute of Poliomyelitis), Laboratory of Biochemistry, Moscow 108819, Russia.ORCID 0000-0002-4128-3989
Yuriy TurchenkoFSASI "Chumakov FSC R&D IBP RAS" (Institute of Poliomyelitis), Laboratory of Biochemistry, Moscow 108819, Russia.ORCID 0000-0003-0869-0045
Alexander LitovFSASI "Chumakov FSC R&D IBP RAS" (Institute of Poliomyelitis), Laboratory of Biology of Arbovirus, Moscow 108819, Russia.
Anna KalyanovaFSASI "Chumakov FSC R&D IBP RAS" (Institute of Poliomyelitis), Laboratory of Biology of Arbovirus, Moscow 108819, Russia.
Alexandra SiniuginaFSASI "Chumakov FSC R&D IBP RAS" (Institute of Poliomyelitis), Moscow 108819, Russia.
Aydar IshmukhametovInstitute of Translational Medicine and Biotechnology, Sechenov First Moscow State Medical University, Moscow 119991, Russia.
Galina KarganovaFSASI "Chumakov FSC R&D IBP RAS" (Institute of Poliomyelitis), Laboratory of Biology of Arbovirus, Moscow 108819, Russia.
Chumakov Institute of Poliomyelitis and Viral Encephalitides · RUSechenov University · RUInSysBio (Russia) · RULomonosov Moscow State University · RU

Funding

Chumakov Institute of Poliomyelitis and Viral Encephalitides 3Ministry of Science and Higher Education of Russia 0837-2019-0003, 0837-2019-0007
6 · The paper itself

Abstract

Tick-borne encephalitis virus (TBEV) and Powassan virus (POWV) are neurotropic tick-borne orthoflaviviruses. They cause mostly asymptomatic infections in hosts, but severe forms with CNS involvement can occur. Studying the early stages of viral infections in humans is challenging, and appropriate animal models are essential for understanding the factors determining the disease severity and for developing emergency prophylaxis and treatment options. In this work, we assessed the model of the early stages of TBEV and POWV mono- and co-infections in

Indexed as

antibody spectrumcognitive impairmentcross-reactive antibodiesflavivirusesinapparent infectionorthoflavivirusesPowassan virusTBE vaccinetick-borne encephalitis virus

Identifiers

PMID38140159
PMCPMC10747564
OpenAlexW4389050345

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.